Cancer Patients Europe (CPE) is proud to announce the launch of a new patient survey aimed at people living with metastatic prostate cancer, as… Read More
On 24–25 September, CPE joined partners from across Europe for the SEISMIC consortium meeting in Barcelona, hosted by Hospital Clínic de Barcelona. SEISMIC is… Read More
From 24–26 September 2026, CPE joined the World Cancer Congress 2026 in Hong Kong, organised by the Union for International Cancer Control (UICC) and… Read More
On 9–10 September 2026, CPE joined partners of the PERIFORMANCE project in Vienna for the in-person project’s Annual Consortium Meeting. PERIFORMANCE is a Horizon… Read More
Too many anti-cancer drugs reach patients without clear answers on the right dose, the right duration, or the right combination. The result: avoidable side… Read More
On 10–11 September 2026, partners of the SALVOVAR project met in Brussels for their annual project meeting, hosted by CPE. SALVOVAR is a European… Read More
CPE, within the SALVOVAR project, is pleased to announce a stakeholder workshop, Building Better Clinical Trials Together: A Stakeholder Dialogue on Pragmatic Trials in Europe, to… Read More
Receiving a cancer diagnosis can be overwhelming. Alongside the emotional impact, patients and their loved ones are often faced with complex and overwhelming medical… Read More
CPE has joined a coalition focused on the advanced therapies and rare diseases, including patient organisations, clinicians, medical societies, academic centres and therapy developers, in endorsing a joint… Read More
Wondering whether a clinical trial could be an option for you or someone you care for? Clinical trial opportunities can be difficult to navigate — eligibility… Read More
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.